{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:59:39Z","timestamp":1786982379045,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Takeda Pharmaceuticals USA, Inc., Lexington, MA, USA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s12325-022-02292-1","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T07:02:42Z","timestamp":1661497362000},"page":"5013-5024","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Five-Year Estimated Glomerular Filtration Rate in Adults with Chronic Hypoparathyroidism Treated with rhPTH(1-84): A Retrospective Cohort Study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6084-5900","authenticated-orcid":false,"given":"Olulade","family":"Ayodele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rejnmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Lax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse","family":"Swallow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira O.","family":"Gosmanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"2292_CR1","doi-asserted-by":"publisher","first-page":"e3557","DOI":"10.1210\/clinem\/dgaa490","volume":"105","author":"KS Chen","year":"2020","unstructured":"Chen KS, Gosmanova EO, Curhan GC, et al. Five-year estimated glomerular filtration rate in patients with hypoparathyroidism treated with and without rhPTH(1\u201384). J Clin Endocrinol Metab. 2020;105:e3557\u201365.","journal-title":"J Clin Endocrinol Metab"},{"key":"2292_CR2","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1007\/s12325-021-01658-1","volume":"38","author":"EO Gosmanova","year":"2021","unstructured":"Gosmanova EO, Chen K, Rejnmark L, et al. Risk of chronic kidney disease and estimated glomerular filtration rate decline in patients with chronic hypoparathyroidism: a retrospective cohort study. Adv Ther. 2021;38:1876\u201388.","journal-title":"Adv Ther"},{"key":"2292_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232842","volume":"15","author":"SH Kim","year":"2020","unstructured":"Kim SH, Rhee Y, Kim YM, et al. Prevalence and complications of nonsurgical hypoparathyroidism in Korea: a nationwide cohort study. PLoS ONE. 2020;15: e0232842.","journal-title":"PLoS ONE"},{"key":"2292_CR4","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1210\/jc.2012-1808","volume":"97","author":"DM Mitchell","year":"2012","unstructured":"Mitchell DM, Regan S, Cooley MR, et al. Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab. 2012;97:4507\u201314.","journal-title":"J Clin Endocrinol Metab"},{"key":"2292_CR5","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/jbmr.1979","volume":"28","author":"L Underbjerg","year":"2013","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res. 2013;28:2277\u201385.","journal-title":"J Bone Miner Res"},{"key":"2292_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/cen.13895","volume":"90","author":"T Vadiveloo","year":"2019","unstructured":"Vadiveloo T, Donnan PT, Leese CJ, Abraham KJ, Leese GP. Increased mortality and morbidity in patients with chronic hypoparathyroidism: a population-based study. Clin Endocrinol (Oxf). 2019;90:285\u201392.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2292_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fendo.2016.00172","volume":"7","author":"EG Abate","year":"2017","unstructured":"Abate EG, Clarke BL. Review of hypoparathyroidism. Front Endocrinol (Lausanne). 2017;7:172.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2292_CR8","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1210\/clinem\/dgaa113","volume":"105","author":"JP Bilezikian","year":"2020","unstructured":"Bilezikian JP. Hypoparathyroidism. J Clin Endocrinol Metab. 2020;105:1722\u201336.","journal-title":"J Clin Endocrinol Metab"},{"key":"2292_CR9","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1210\/jc.2015-3907","volume":"101","author":"ML Brandi","year":"2016","unstructured":"Brandi ML, Bilezikian JP, Shoback D, et al. Management of hypoparathyroidism: summary statement and guidelines. J Clin Endocrinol Metab. 2016;101:2273\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"2292_CR10","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-18-0609","volume":"180","author":"AA Khan","year":"2019","unstructured":"Khan AA, Koch C, Van Uum SHM, et al. Standards of care for hypoparathyroidism in adults: a Canadian and international consensus. Eur J Endocrinol. 2019;180:P1\u201322.","journal-title":"Eur J Endocrinol"},{"key":"2292_CR11","first-page":"10","volume":"2018","author":"E Letavernier","year":"2018","unstructured":"Letavernier E, Daudon M. Vitamin\u00a0D, hypercalciuria and kidney stones. Nutrients. 2018;2018:10.","journal-title":"Nutrients"},{"key":"2292_CR12","doi-asserted-by":"publisher","first-page":"F1243","DOI":"10.1152\/ajprenal.00211.2016","volume":"311","author":"B Oliveira","year":"2016","unstructured":"Oliveira B, Kleta R, Bockenhauer D, Walsh SB. Genetic, pathophysiological, and clinical aspects of nephrocalcinosis. Am J Physiol Renal Physiol. 2016;311:F1243\u201352.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2292_CR13","unstructured":"Natpar\u00ae parathyroid hormone. Dublin, Ireland: Shire Pharmaceuticals Ireland Limited; 2020."},{"key":"2292_CR14","unstructured":"Natpara\u00ae parathyroid hormone. Lexington, MA, USA: Shire-NPS Pharmaceuticals, Inc.; 2020."},{"key":"2292_CR15","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1210\/jc.2019-01010","volume":"104","author":"M Mannstadt","year":"2019","unstructured":"Mannstadt M, Clarke BL, Bilezikian JP, et al. Safety and efficacy of 5 years of treatment with recombinant human parathyroid hormone in adults with hypoparathyroidism. J Clin Endocrinol Metab. 2019;104:5136\u201347.","journal-title":"J Clin Endocrinol Metab"},{"key":"2292_CR16","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.1210\/jc.2019-00893","volume":"104","author":"YD Tay","year":"2019","unstructured":"Tay YD, Tabacco G, Cusano NE, et al. Therapy of hypoparathyroidism with rhPTH(1\u201384): a prospective, 8-year investigation of efficacy and safety. J Clin Endocrinol Metab. 2019;104:5601\u201310.","journal-title":"J Clin Endocrinol Metab"},{"key":"2292_CR17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1053\/j.ajkd.2014.07.030","volume":"64","author":"AS Levey","year":"2014","unstructured":"Levey AS, Inker LA, Matsushita K, et al. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis. 2014;64:821\u201335.","journal-title":"Am J Kidney Dis"},{"key":"2292_CR18","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1053\/j.ajkd.2014.08.018","volume":"64","author":"HJ Lambers Heerspink","year":"2014","unstructured":"Lambers Heerspink HJ, Tighiouart H, Sang Y, et al. GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials. Am J Kidney Dis. 2014;64:860\u20136.","journal-title":"Am J Kidney Dis"},{"key":"2292_CR19","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1681\/ASN.2019010008","volume":"30","author":"ME Grams","year":"2019","unstructured":"Grams ME, Sang Y, Ballew SH, et al. Evaluating glomerular filtration rate slope as a surrogate end point for ESKD in clinical trials: an individual participant meta-analysis of observational data. J Am Soc Nephrol. 2019;30:1746\u201355.","journal-title":"J Am Soc Nephrol"},{"key":"2292_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"2292_CR21","doi-asserted-by":"crossref","unstructured":"Mannstadt M, Clarke BL, Vokes T, et al. Efficacy and safety of recombinant human parathyroid hormone (1\u201384) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomized, phase 3 study. Lancet Diabetes Endocrinol. 2013;1:275\u201383 [erratum: Lancet Diabetes Endocrinol. 2014;2(1):e3].","DOI":"10.1016\/S2213-8587(13)70106-2"},{"key":"2292_CR22","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","volume":"90","author":"P Evenepoel","year":"2016","unstructured":"Evenepoel P, Bover J, Urena-Torres P. Parathyroid hormone metabolism and signaling in health and chronic kidney disease. Kidney Int. 2016;90:1184\u201390.","journal-title":"Kidney Int"},{"key":"2292_CR23","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1080\/13696998.2019.1624081","volume":"22","author":"K Chen","year":"2019","unstructured":"Chen K, Krasner A, Li N, et al. Clinical burden and healthcare resource utilization among patients with chronic hypoparathyroidism, overall and by adequately vs not adequately controlled disease: a multi-country chart review. J Med Econ. 2019;22:1141\u201352.","journal-title":"J Med Econ"},{"key":"2292_CR24","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ando.2021.07.085","volume":"82","author":"F Fanget","year":"2021","unstructured":"Fanget F, Demarchi MS, Maillard L, et al. Hypoparathyroidism: consequences, economic impact, and perspectives. A case series and systematic review. Ann Endocrinol (Paris). 2021;82:572\u201381.","journal-title":"Ann Endocrinol (Paris)"},{"key":"2292_CR25","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/EJE-21-1044","volume":"186","author":"J Bollerslev","year":"2021","unstructured":"Bollerslev J, Rejnmark L, Zahn A, et al. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE educational program of parathyroid disorders. Eur J Endocrinol. 2021;186:R33\u201363.","journal-title":"Eur J Endocrinol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02292-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-022-02292-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02292-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T11:43:05Z","timestamp":1664538185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-022-02292-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["2292"],"URL":"https:\/\/doi.org\/10.1007\/s12325-022-02292-1","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]},"assertion":[{"value":"29 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}